Predicting factors of successful postsurgical remnant ablation with I-131 in patients with differentiated thyroid carcinoma

被引：0
|
作者：
Fallahi, B. [1 ]
Beiki, D. [1 ]
Takavar, A. [1 ]
Eftekhari, M. [1 ]
Fard-Esfahani, A. [1 ]
Gilani, K. Ansari [1 ]
Saghari, M. [1 ]
机构：
[1] Univ Tehran Med Sci, Res Inst Nucl Med, Tehran, Iran
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [31] Clinical factors related to successful ablation of I-131 therapy with 5,550 MBq for papillary thyroid carcinoma
    Song, H.
    Cho, S.
    Chong, A.
    Oh, J.
    Kang, S.
    Yoo, S.
    Byun, B.
    Min, J.
    Bom, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S345 - S346
  • [32] I-131 ablation therapy in patients with differentiated thyroid cancer: efficacy of different therapeutic protocols
    Salvatori, M
    Rufini, V
    Leccisotti, L
    Perotti, G
    Maussier, ML
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S465 - S465
  • [33] I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
    Yan Shengguang
    Ji-Eun, Choi
    He Lijuan
    MEDICAL SCIENCE MONITOR, 2016, 22 : 2439 - 2450
  • [34] Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma
    Long, Bin
    Li, Linfa
    Yao, Lifang
    Chen, Shoucong
    Yi, Heqing
    Ye, Xuemei
    Xu, Dong
    Wu, Peng
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (08) : 244 - 247
  • [35] Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma
    Oral, Aylin
    Yazici, Bulent
    Eraslan, Cenk
    Burak, Zeynep
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2018, 27 (03) : 99 - 106
  • [36] Contribution of I-131 SPECT/CT on Staging of Differentiated Thyroid Carcinoma
    De Bonilla Damia, A.
    Cambil Molina, T.
    Calvo Moron, M.
    De la Riva Perez, P.
    Borbon Arce, M.
    Castro Montano, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S448 - S448
  • [37] INADEQUACY OF MODERATE DOSE OF I-131 FOR ABLATION OF THYROID REMNANTS FOLLOWING SURGERY FOR DIFFERENTIATED THYROID-CARCINOMA (DTC)
    SIDDIQUI, AR
    EDMONDSON, J
    WELLMAN, HN
    PARK, HM
    SCHNUTE, R
    JOHNSTON, CC
    JOURNAL OF NUCLEAR MEDICINE, 1980, 21 (06) : P30 - P30
  • [38] Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy
    de Klerk, JMH
    de Keizer, B
    Zelissen, PMJ
    Lips, CMJ
    Koppeschaar, HPF
    NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (06) : 529 - 532
  • [39] 99mTc scintigraphy predicts a successful of thyroid remnant radioiodine ablation in patients with differentiated thyroid carcinoma
    Zehnati, T.
    Benrabah, M.
    Bouzidi, A.
    Lakehal, A.
    Ouyed, T.
    Hamlat, R.
    Redhouane, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S557 - S558
  • [40] Outcome of different activity of 131I for first remnant ablation in the patients with differentiated thyroid cancer
    Chen, Yonghui
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345